Assessing the Safety, Performance, and User Experience of the Tandem Mobi Automated Insulin Delivery System Among Young Competitive Athletes in Real-world Settings.

Exclusion Criteria

• •Concomitant disease that influences metabolic control or HbA1c interpretation
• •Individual has any unresolved adverse skin condition in the area of sensor or device placement (e.g., psoriasis, rash, Staphylococcus infection)
• •Use of antidiabetic agents other than insulin
• •Two or more episodes of severe hypoglycemia (hypoglycemia requiring treatment by another person) within the previous 6 months
• •One or more episodes of ketoacidosis requiring hospitalization within 6 months prior to screening
• •Individual has a positive pregnancy screening test